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systemic challenges. To more fully investigate these complex dynamics, we measured levels of reactive oxygen metabolites (ROM) and biological antioxidant potential (BAP) in the blood of 19 patients receiving treatment for acute stage KD. These measurements were designed to evaluate oxidative stress levels and the activity of the ROS elimination system, respectively, in immunocompromised individuals.
In addition, having used ROM and BAP for this oxidation stress evaluation has a significant meaning. Up to now, the measurement of the oxidant stress was not easy. Electron spin resonance (ESR) method as a golden standard of the free radical measurement requires skill and expertise because of the use of an extremely complex technique, and the measurements of various oxidative-stress markers already known are time-consuming because of their use of immunological methods. Therefore, there were a lot of problems in clinical use although they were useful for the investigative purpose. However, the measurement of ROM and BAP is very handy. We can get both results in 10 min and it shows excellent reproducibility. To sum up, handiness, promptness, and reproducibility are all factors that are indispensable characters in the clinical application. In this respect, we can estimate high usefulness of the procedure that makes a clear distinction with the current oxidation stress evaluation.
Methods
This study focused on 19 patients (Table 1 ) with acute KD (median age: 1.8 years, range: 0.8-5.8 years) and 7 control subjects (median age: 1.1 years, range: 0.8-6.3 years). All patients were diagnosed with KD according to the diagnostic standard of the Japanese Society of Kawasaki Disease (JSKD). 19 As recommended by the JSKD, patients were treated with intravenous immunoglobulin (IVIG; 2 g/kg single administration) and oral aspirin (30 mg · kg -1 · day -1 ). 20 Blood samples were collected immediately before, immediately after, and 2 weeks after the IVIG treatment so that ROM, BAP, high-sensitivity C-reactive protein (hs-CRP), interleukin (IL)-1,2,6, and tumor necrosis factor (TNF)-α levels could be measured. Blood samples were also collected from control subjects, for comparison. When possible, blood sampling was performed in the early morning, after patients had fasted overnight.
Thirteen of the patients responded well to treatment (Group A). The remaining 6 patients continued to experience a fever of 37.5ºC or more during the 48 h following the initial IVIG administration, and required additional IVIG or steroid treatment (Group B). However, the fever had decreased to 37.5°C or below by the time of the final blood sampling.
All study protocols were approved by the ethical committee at the Kyoto Prefectural University of Medicine Graduate School of Medical Science. Informed written consent was obtained from the parents of all study subjects and particular care was taken to protect human rights and personal information. 
Measuring ROM and BAP Levels
The chromatic change that results from this process can be measured by with a photometer at 505 nm, and is directly proportional to the ability of the plasma to reduce ROS. Ten-microliter blood sample aliquots were required from each patient for these protocols. The samples were mixed with the colored solution and incubated for 5 min at 37°C prior to photometric analysis. The pH of the FeCl3 -AT solution was 2.3 and it remained in the range of 2.3-2.4 throughout the procedure.
Statistical Analysis
Data values are presented as medians and interquartile ranges because almost all the values are not normally distributed. All data were analyzed using SPSS software version 11.0 (SPSS Japan Inc, Tokyo, Japan). Paired t-tests or Mann-Whitney Utests were used to make comparisons between groups. Significance was defined as P<0.05.
Results

Change of Each Parameter
We measured each parameter in all patients and calculated the change rate by assuming the value at pre-IVIG to be 100 ( Table 2) . We examined whether there was a correlation in the change of the oxidant stress and that of hs-CRP and the proinflammatory cytokine.
The levels of ROM and BAP did not show the correlation with neither hs-CRP nor the proinflammatory cytokines in their variation from pre-IVIG to immediately post-IVIG. The ROM showed the correlation only hs-CRP, although BAP did 
ROM and BAP Levels in the Control Group
In the control group, the ROM level was 312 (327/300) (median (upper/lower quartile U.CARR) and the BAP level was 2,674 (2,745/2,572) (mol/L) ( It is important to note that ROM level was statistically similar in Groups A and B immediately before the treatment. Thus, the different responses to the IVIG treatment were not caused by differences in levels of ROS.
Dynamics of BAP During the Acute Stage of KD (Figure 2)
In Group A, BAP did not change significantly from immediately before the IVIG treatment (2,705 (2,883/2,510) mol/L) to immediately afterward (2,714 (2,940/2,462) mol/L). However, BAP was obviously higher 2 weeks after the treatment (2,778 (3,015/2,705) mol/L). This was significantly higher than both the baseline value (P<0.01) and that recorded immediately after the treatment (P<0.05).
Immediately before the IVIG treatment, BAP was significantly lower in Group B than in both the control group (P<0.01) and in Group A (P<0.05). Unlike the pattern observed in Group A, BAP levels in Group B did not change significantly from immediately before the treatment (2,474 (2,557/ 2,413) mol/L), to immediately after the treatment (2,438 (2,626/2,313) mol/L), to 2 weeks after the treatment (2,622 (2,703/2,380) mol/L).
We did not perform multiple regression analysis because we could not find any significant variable excluding BAP in univariate analysis. Furthermore, only BAP was still selected although the model for the multivariate analysis. The area under the receiver operating curve is 0.80 (95% confidence interval 0.59-0.99).
Discussion
Here, we found that the reduction of ROM from immediately after the IVIG to 2 weeks after IVIG correlated to the movement of hs-CRP, which is a general inflammatory marker. The fact might suggest their close relationship between the oxidative stress and inflammation. Furthermore, we found that patients with acute stage KD have abnormally high levels of ROM in their blood, indicating an increased production of ROS. When given an IVIG treatment, some patients experienced ROM reductions, while others did not, suggesting that this treatment will not always be effective in suppressing ROS production.
Baseline BAP levels were either similar to (Group A) or lower than (Group B) those in control individuals. Either way, this indicates that the KD patients had not launched an endogenous antioxidant response. However, patients in Group A experienced clear increases in BAP 2 weeks after receiving IVIG, demonstrating the effectiveness of this treatment in stimulating antioxidant activity. The pattern of change in BAP level was similar among patients in Group B, but their absolute BAP values were significantly lower than those in both control individuals and IVIG-treated patients in Group A. Again, this indicates that while the IVIG treatment is effective against acute KD symptoms, it cannot be relied upon to work equally well in all cases.
In cases of KD-associated vasculitis, cytokines such as TNF-α and IL-6 increase during the acute stage in response to the release of various prophlogistic substances from the infiltrated monocyte/macrophage. 11- 15 The released TNF-α induces vascular endothelial cells to express adhesive factors that prime neutrophils and monocytes. Furthermore, it also acts on endothelial cells and fibroblasts, induces various chemokines, facilitates migration of inflammatory cells to the inflammatory site, and increases production of cytokines such as IL-6, thus increasing inflammation. NAD(P)H oxidase is then activated in the inflammatory cells (eg, neutrophils and macrophages) that were primed by the inflammatory cytokines; this leads to the rapid production of a large amount of ROS. 25 Inducible nitric oxide (NO) synthase in the inflammatory cells produces NO, an unstable radical that changes to peroxynitrite (ONOO-) when exposed to ROS. Peroxynitrite is extremely responsive, and its strong oxidation activity is capable of directly disabling vascular tissues. 26 We suspect that this might be an important element driving the progression of vascular disorders associated with KD. NAD(P)H oxidase 27 on the endothelial cell membrane also reacts with the xanthine oxidase system in vascular endothelial cells 28 and TNF-α in the blood, and causes the activation of the arachidonate cascade, which generates prophlogistic substances such as leukotriene 29 and produces ROS as a by-product of metabolism.
The ROM measured in this study is a generic name for organic molecules that have been oxidized by ROS such as hydroperoxide (R-OOH). One important ROM is hydroxyperoxide, which is produced by the oxidization of physiologically vital organic molecules such as lipids, proteins, and nucleic acids. The presence of hydroxyperoxide is considered an excellent marker of oxidative damage, 30-33 and can easily be measured by the FREE ® system used in this study. Results from this method correlate highly with those produced using ESR methodologies. 34, 35 The patterns of ROM decrease shown in both treatment groups here are not surprising, given what is currently known about KD and the inflammation pathway. The more novel result of this work is the discovery that ROS increased so rapidly. Additionally, our techniques here have shown that the ROM measurement is useful in clinical situations for assessing inflammatory dynamics in lesions, as well as investigating the efficacy of inflammation alleviation treatments. Further, our results clearly demonstrate that the IVIG inflammation alleviation treatment cannot be relied upon to significantly reduce inflammation in all patients, although it does reduce ROS production more often than not (eg, in 13 of 19 patients).
There are also homeostasis mechanisms that combat the presence of ROS by eliminating these elements in order to maintain the balance between oxidization and antioxidization. 36, 37 Antioxidants have both endogenous (eg, albumin, YAHATA T et al.
transferrin, ceruloplasmin, bilirubin, ureic acid, reduced glutathione, etc) and exogenous (eg, tocopherol, carotin, ubiquinone, ascorbic acid, methionine, flavonoid, polyphenol, etc) origins. The FREE ® system, used here to measure the comprehensive antioxidative potency in patients' blood, is based on the same principle as the ferric reducing ability of plasma assay method, 38 which has widely been recognized as an effective measurement technique.
Here, we found that changes in BAP in acute KD patients did not mirror changes in ROS. Furthermore, BAP activity was clearly lower in some patients (Group B) than in others (Group A), even after the IVIG treatment. Oxidative stress alleviation was delayed in Group B, and we hypothesize that this led to a build-up of abnormal ROS, leading to further increases in oxidative stress and additional inflammation, via a positive feedback loop. This phenomenon might be one factor leading to the higher rate of coronary arterial disorders in IVIG-unresponsive cases. 39, 40 The results of our work also suggest that baseline BAP levels can be used to predict whether patients will respond well to IVIG treatment and to assess the clinical conditions of vasculitis. Previously, it has been shown that prolonged inflammation, such as that likely present in Group B, increases the rate at which patients suffer coronary arterial complications. 41 Therefore, it is important to select an effective initial treatment in order to decrease inflammation as early and as rapidly as possible. This can be facilitated via the use of an appropriate biomarker that can be used as an index of the severity of inflammation. Our work indicates that BAP levels, either before or during treatment, can be used for this purpose. Moreover, BAP measurements can be performed within a few minutes following sample collection, which further enhances the clinical usefulness of this modality.
Although we have not directly shown a link between the clinical conditions of KD and activity of the oxidation/reduction control mechanism, we believe there is good evidence suggesting that the two are closely related: In patients with KD-associated coronary arteritis, inflammatory cells such as macrophages remain in place for approximately 2-3 months after infiltration. Since these macrophages are producing ROS, the coronary arteries are exposed to excessive oxidative stress for long periods of time. Thus, in patients who respond to IVIG treatment by upregulating their antioxidant activity, vascular disorders should be shorter-lived and vascular remodeling should proceed at a higher rate, than among patients who do not respond to the IVIG treatment. In order to investigate this hypothesis, it will be important to plot ROM and BAP values, as well as document clinical conditions, of a large study group over a long study period.
Further study is needed to make this research results more significant because the number of cases is still little in this study. The relationship between the antioxidative potency and the IVIG reactiveness obtained this time is a very intriguing result. We think that further examination leads to the elucidation of the cause of KD and the proposal of new treatment methods.
Conclusion
We have shown that patients with acute stage KD suffer from increased levels of oxidative stress, which, in most cases, can be reduced via the anti-inflammatory activities of IVIG. We also found that antioxidant activities increase slowly, relative to changes in ROS levels. Nearly a third of patients examined here responded poorly to the IVIG treatment, and these individuals had lower initial BAP levels than either controls or IVIG-responsive patients. This suggests that BAP can be used to predict the likelihood that anti-inflammatory treatments will be effective in KD patients. The ROM measurement, also, might be useful in a clinical setting, for evaluating inflammatory dynamics in lesions and tracking the effectiveness of anti-inflammatory treatments.
